ISRG vs. EW, ZBH, ALGN, REGN, ZTS, VRTX, BSX, GSK, HCA, and BDX
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Align Technology (ALGN), Regeneron Pharmaceuticals (REGN), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX), Boston Scientific (BSX), GSK (GSK), HCA Healthcare (HCA), and Becton, Dickinson and (BDX). These companies are all part of the "medical" sector.
Intuitive Surgical vs.
Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking.
In the previous week, Edwards Lifesciences had 1 more articles in the media than Intuitive Surgical. MarketBeat recorded 13 mentions for Edwards Lifesciences and 12 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 0.74 beat Edwards Lifesciences' score of 0.17 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Edwards Lifesciences presently has a consensus target price of $88.95, indicating a potential upside of 8.76%. Intuitive Surgical has a consensus target price of $273.83, indicating a potential upside of 10.77%. Given Intuitive Surgical's stronger consensus rating and higher probable upside, analysts plainly believe Intuitive Surgical is more favorable than Edwards Lifesciences.
Edwards Lifesciences received 296 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 72.89% of users gave Edwards Lifesciences an outperform vote while only 70.22% of users gave Intuitive Surgical an outperform vote.
Edwards Lifesciences has higher earnings, but lower revenue than Intuitive Surgical. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Edwards Lifesciences has a net margin of 28.27% compared to Intuitive Surgical's net margin of 21.25%. Edwards Lifesciences' return on equity of 26.05% beat Intuitive Surgical's return on equity.
Edwards Lifesciences has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.
80.4% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 82.0% of Intuitive Surgical shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.9% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Intuitive Surgical beats Edwards Lifesciences on 10 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
